5th Optimizing Hybrid Clinical Trials Summit 2024
When:
Wednesday, Sep 11, 2024 9:00a -
Thursday, Sep 12, 2024 3:30p
Wednesday, Sep 11, 2024 9:00a -
Thursday, Sep 12, 2024 3:30p
Where:
Hilton Boston Logan Airport
One Hotel Drive
Boston, Massachusetts 02128
Admission:
$0.00 - $3749.00
Hosted by:
Categories:
Lectures & Conferences
Event website:
https://go.evvnt.com/2380958-0?pid=5248
DCTs were proclaimed as the silver bullet during the pandemic, but it is now clear that they are not as cheap or easy as expected.
The 5th Optimizing Hybrid Clinical Trials Summit is uniting stakeholders in Clinical Operations, Innovation, Procurement and Digital Health and more to share practical case studies in building a budget and financial business case to run DCTs, securing end-to-end data flow, and managing data integrity and quality to operationalize hybrid trials.
With practical insight into building a compelling financial case to run hybrid trials, enhancing data quality and integrity with electronic data capture systems and employing digital solutions to reduce patient burden, join 80+ senior stakeholders including Pfizer, Bayer, Eli Lilly and Co, Astellas, UCB, AbbVie and more to explore strategies to optimize hybrid clinical trials and enhance DEandI and patient access, improve operational efficiency and leverage remote data collection to demonstrate efficacy and safety in DCTs.
URLs:
Tickets: https://go.evvnt.com/2380958-2?pid=5248
Brochure: https://go.evvnt.com/2380958-3?pid=5248
Prices:
Drug Developer Pricing - Full Conference : USD 0.00,
Vendor Pricing - Full Conference : USD 3749.00
Speakers: Alanna Caffas, Chief Executive Officer, Veterans Health Foundation, Amy Bohn, Director, DCT Operations, Bayer, Craig Lipset, Co-Chair, Decentralized Trials and Research Alliance (DTRA), Dennis Salotti, Executive Director and Head, Clinical Outsourcing and Innovation, Jazz Pharmaceuticals, Janet Moga, DCT Operations Lead, Astellas Pharmaceuticals, Kenneth Getz, Executive Director, Research Professor (PHCM), Tufts Center For The Study of Drug Development, Len Rosenburg, Head of Clinical Operations, Beat AML, a division of The Leukemia and Lymphoma Society (LLS), Marjorie Zettler, Senior Director of Clinical Science, Accutar Biotech, Martina Endzhova, Global Category Lead, Bayer, Michael Podias, Program Manager Clinical Trial Innovation, Pfizer, Michelle Crouthamel, Head of Digital Science, AbbVie, Sarah Bilali, Global Regulatory Affairs Lead, UCB, Sarah Small, Associate Director, Patient Centricity, Moderna, Stephanie Jones, Senior Manager, Vendor Relationship Management, Gilead Sciences, Teri Wright, Director of Clinical Lab Services and Devices -Innovation, Eli Lilly and Co, Xuemei Cai, Senior Medical Director, Digital Medicine, Pfizer
